https://2medical.news/2026/05/26/outcomes-of-patients-with-hepatocellular-carcinoma-treated-with-durvalumab-plus-tremelimumab-in-real-world-clinical-practice-who-met-or-did-not-meet-the-inclusion-criteria-for-the-phase-3-himalaya-tri/2 Medical Newsen-gb2026-05-26T07:00:21+00:00Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA TrialHCChttps://2medical.news/2026/05/25/direct-oral-anticoagulant-consumption-and-the-risk-of-acute-interstitial-lung-diseases-a-case-crossover-study-using-japanese-administrative-data/2 Medical Newsen-gb2026-05-25T07:00:04+00:00Direct Oral Anticoagulant Consumption and the Risk of Acute Interstitial Lung Diseases: A Case-Crossover Study Using Japanese Administrative DataDOAC, ILD